BlackRock reports 6.9% stake in Prothena
BlackRock, Inc. reports beneficial ownership of common stock of Prothena Corporation plc on an amended Schedule 13G. BlackRock reports beneficial ownership of 3,587,480 shares of Prothena common stock, representing 6.9% of the outstanding class.
Rhea-AI Filing Summary
BlackRock, Inc. reports beneficial ownership of common stock of Prothena Corporation plc on an amended Schedule 13G. BlackRock reports beneficial ownership of 3,587,480 shares of Prothena common stock, representing 6.9% of the outstanding class.
BlackRock has sole voting power over 3,533,090 shares and sole dispositive power over 3,587,480 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no single client holds more than five percent of Prothena’s outstanding common shares.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
Schedule 13G regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Prothena (PRTA) does BlackRock currently report owning?
Does any single BlackRock client own more than 5% of Prothena (PRTA)?
What type of filing did BlackRock submit for its Prothena (PRTA) holdings?
Who signed the BlackRock ownership report for Prothena (PRTA) and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.